LOADING
Comparing Pfizer Inc (PFE) and Nike Inc (NKE) across the Health Care and Consumer Discretionary sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PFE | NKE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $158.5B | $52.1B |
| P/E Ratio | 37.1 | 16.5 |
| Forward P/E | 9.7 | 21.0 |
| PEG Ratio | 12.89 | 1.40 |
| EPS | $0.75 | $2.13 |
| Revenue Growth (YoY) | 2.6% | -1.1% |
| Profit Margin | 6.8% | 6.7% |
| Return on Equity | 5.0% | 22.1% |
| Dividend Yield | 6.12% | 4.60% |
| Beta | 0.30 | 1.11 |
| 52-Week High | $29.21 | $70.08 |
| 52-Week Low | $22.57 | $31.97 |
| Volume | -- | -- |
Pfizer Inc is the larger company by market capitalization. Nike Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Pfizer Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.